FIELD: biotechnology.
SUBSTANCE: invention relates to the field of biotechnology, in particular to new gold nanoconjugates with therapeutic agents, and can be used in medicine. The invention makes it possible to obtain a conjugate of a gold nanoparticle with doxorubicin and bombesin, in which stabilized dithiolated diethylenetriaminepentaacetic acid (DTDTPA) is bound to the surface of the gold nanoparticle, doxorubicin molecules are attached to the terminal amino groups of DTDTPA, and bombesin molecules are attached to the surface of the gold nanoparticle through the terminal thioctic acid.
EFFECT: invention discloses the possibility of using such a nanoconjugate as part of a pharmaceutical composition for targeted delivery of a therapeutic agent to tumor cells.
17 cl, 10 ex, 4 tbl, 20 dwg
Title |
Year |
Author |
Number |
CONJUGATE OF NANOPARTICLES OF GOLD-MAGNETITE COMPOSITION WITH FUNCTIONAL MOLECULE (OPTIONS) AND METHOD OF USE (OPTIONS) |
2023 |
- Nikitin Maksim Petrovich
- Mochalova Elizaveta Nikitichna
- Sizikov Artem Aleksandrovich
- Kolychev Evgenii Leonidovich
- Ivantsova Polina Mikhailovna
|
RU2811020C1 |
NANOPARTICLE OF GOLD-MAGNETITE COMPOSITION, METHOD OF PRODUCING NANOPARTICLE (VERSIONS), CONJUGATE BASED ON IT (VERSIONS), METHOD OF PRODUCING CONJUGATE AND TEST KIT |
2023 |
- Ivantsova Polina Mikhajlovna
- Kolychev Evgenij Leonidovich
- Mochalova Elizaveta Nikitichna
- Sizikov Artem Aleksandrovich
- Nikitin Maksim Petrovich
|
RU2814660C1 |
NANOAGENTS FOR SCREENING PATHOGENIC STRAINS OF MULTIDRUG-RESISTANT BACTERIA AND METHOD OF PREPARATION |
2022 |
- Nikitin Maksim Petrovich
- Ryngach Alina
|
RU2804488C1 |
PEPTIDES OR THEIR PHARMACEUTICALLY ACCEPTABLE ACIDS OR SALTS, PHARMACEUTICAL COMPOSITION SHOWING ANTAGONISTIC ACTIVITY WITH RESPECT TO BOMBESINE, METHOD OF TREATMENT OF MAMMALIAN WITH CANCER |
1994 |
- Ehndrju V.Skehlli
- Ren Zhi Kehj
|
RU2114118C1 |
METHOD AND COMPOSITION FOR TREATING CANCER |
2011 |
- Kabanov Aleksandr V
- Alakhova Dar'Ja J
- Zhao Ji
|
RU2541100C2 |
THERAPEUTIC PEPTIDES OR THEIR PHARMACEUTICALLY ACCEPTABLE SALTS |
1989 |
- Dehvid Kh.Koj[Us]
- Zhak-P'Er Moro[Us]
- Dzhon E.Tejlor[Us]
- Sun Kh'Juk Kim[Us]
|
RU2088592C1 |
PEPTIDES FOR INHIBITING ANGIOGENESIS |
2016 |
- Komarova Yulia A.
- Rosenblatt Mark
- Malik Asrar B.
|
RU2708375C2 |
METHODS AND COMPOSITIONS FOR TUSC2-IMMUNOTHERAPY |
2017 |
|
RU2755903C2 |
GEL COMPOSITION FOR RADIATION THERAPY UNDER VISUAL CONTROL |
2014 |
- Andresen Tomas Lars
- Jelk Rasmus Irming
- Albrekhtsen Morten
|
RU2703303C2 |
GRPR ANTAGONISTS FOR DETECTING, DIAGNOSING AND TREATING GRPR-POSITIVE ONCOLOGICAL DISEASE |
2013 |
- Maina-Nock, Theodosia
- Nock, Berthold, Artur
- De Jong Hendriks, Marion
|
RU2821944C2 |